Pathophysiology of ANCA-associated glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 14, Issue 6, 1999, Pages 1366-1375

  Muller Kobold, Anneke C ^a   Van Der Geld, Ymke M ^b   Limburg, Pieter C ^b   Cohen Tervaert, Jan Willem ^b   Kallenberg, Cees G M ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

ANCA; Glomerulonephritis; Neutrophil; Pathophysiology; Vasculitis

Indexed keywords

ANTIGEN; BASEMENT MEMBRANE ANTIBODY; CELL ADHESION MOLECULE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; LEUKOCYTE ELASTASE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIGEN EXPRESSION; BLOOD VESSEL INJURY; CAPILLARY WALL; CELL ACTIVATION; CHURG STRAUSS SYNDROME; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; IMMUNOGLOBULIN DEPOSITION; INFLAMMATION; KIDNEY FUNCTION; MICROALBUMINURIA; MONOCYTE; NECROSIS; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; REMISSION; REVIEW; SYSTEMIC VASCULITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ENDOTHELIUM, VASCULAR; EPITOPES; GLOMERULONEPHRITIS; HUMANS; IMMUNOGLOBULIN G; MONOCYTES; NEUTROPHILS; VASCULITIS;

EID: 0032972762     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.6.1366     Document Type: Review

References (105)

1. Couser WG. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanism and therapy. Am J Kidney Dis 1988; 11: 449-464
2. Harris AA, Falk RJ, Jennette JC. Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localisation: renal biopsy teaching case. Am J Kidney Dis 1998; 32: 179-184
3. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15
4. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997; 337: 1512-1523
5. Cohen Tervaert JW, Mulder L, Stegeman C et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52: 115-120
6. Cohen Tervaert JW, van der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anti-neutrophil cytoplasmic antibodies. Arch Intern Med 1989; 149: 2461-2465
7. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxydase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657
8. Cohen Tervaert JW, Goldschmeding R, Elema JD et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990; 33: 1264-1272
9. Cohen Tervaert JW, Limburg PC, Elema JD et al. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991; 91: 59-66
10. Guillevin L, Visser H, Noel LH et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol 1993; 20: 1345-1349
11. Gaskin G, Savage CO, Ryan JJ et al. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991; 6: 689-694
12. Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994; 120: 12-17
13. Jayne DR, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. Q J Med 1995; 88: 127-133
14. Egner W, Chapel HM. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 1990; 82: 244-249
15. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-371
16. Hoffman GS, Kerr GS. Rise in ANCA titer: to treat or not to treat [letter]. Am J Med 1995; 98: 102-103
17. Cohen Tervaert JW, Huitema MG, Hene RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-711
18. Heeringa P, Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int 1998; 53: 253-263
19. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87: 4115-4119
20. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leukocyte Biol 1991; 50: 539-546
21. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994; 95: 244-250
22. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase 3, alphal-antitrypsin, and Fcgamma receptors. J Clin Invest 1997; 100: 1416-1424
23. Hallett MB, Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today 1995; 16: 264-268
24. Perlmutter DH, Joslin G, Nelson P, Schasteen C, Adams SP, Fallon RJ. Endocytosis and degradation of alpha-1 antitrypsin protease complexes is mediated by the serpin-enzyme complex receptor. J Biol Chem 1990; 265: 16713-16716
25. Johansson MW, Patarroyo M, Oberg F, Siegbahn A, Nilsson K. Myeloperoxidase mediates cell adhesion via the alpha M/beta 2 integrin (Mac-1, CD11b, CD18). J Cell Sci 1997; 110: 1133-1139
26. Zimmerman F, Andrassy K, Hansch M. Surface expression of polymorphonuclear neutrophil (PMN) elastase: beta 2 integrins may function as binding site. Clin Exp Immunol 1998; 112 [Suppl 1]: 40 (abstract)
27. Campanelli D, Melchior M, Fu Y et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 1990; 172: 1709-1715
28. Gilligan HM, Bredy B, Brady HR et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apototic neutrophils in the apsence of neutrophil priming. J Exp Med 1996; 184: 2231-2241
29. Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 1997; 8: 386-394
30. van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14: 215-221
31. van de Winkel JGJ, Capel JA. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14: 215-221
32. Mulder AH, Stegeman CA, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 1995; 101: 227-232
33. Brouwer E, Cohen Tervaert JW, Horst G et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991; 83: 379-386
34. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994; 98: 270-278
35. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994; 153: 1271-1280
36. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995; 86: 3189-3195
37. Kurlander RJ. Blockade of Fc receptor mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens. J Immunol 1983; 131: 140-145
38. Radford DJ, Lord JM, Savage COS. ANCA activation of human neutrophils induces tyrosine phosphorylation and translocation of protein kinase C. Clin Exp Immunol 1998; 112: 39 (Abstract)
39. Radford DJ, Ben-Smith A, Savage COS. Further determination of the signaling pathways involved in the ANCA activated respiratory burst. Clin Exp Immunol 1998; 112: 39 (Abstract)
40. Tse WY, Radford DJ, Nash GB, Savage COS. Signal pathways of ANCA-induced actin reorganisation in neutrophils. Clin Exp Immunol 1998; 112: 39 (Abstract)
41. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15: 203-234
42. Downey GP, Fukushima T, Fialkow L, Waddell TK. Intracellular signaling in neutrophil priming and activation. Semin Cell Biol 1995; 6: 345-356
43. Berton G, Yan SR, Fumagalli L, Lowell CA. Neutrophil activation by adhesion: mechanisms and pathophysiological implications. Int J Clin Lab Res 1996; 26: 160-177
44. Joslin G, Griffin GL, August AM et al. The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide. J Clin Invest 1992; 90: 1150-1154
45. 2+ in neutrophil-like HL-60 cells: effect of chemotactic peptide antagonist BocMLF. Peptides 1995; 16: 1019-1024
46. Lub M, van Kooyk Y, Figdor CG. Ins and outs of LFA-1. Immunol Today 1995; 16: 479-483
47. Grimminger F, Hattar K, Papavassilis C, Temmesfeld B, Csernok E, Gross WL. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of arachidonic acid and leukotriene B4 generation. J Exp Med 1996; 184: 1567-1572
48. Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage COS. IL-1 beta production by human polymorphonuclear leukocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol 1996; 106: 273-279
49. Casselman BL, Kilgore KS, Miller BF, Warren JS. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 1995; 126: 495-502
50. Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis. Clin Exp Immunol 1997; 107: 513-519
51. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376
52. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41: 375-383
53. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathot 1992; 141: 335-342
54. Mayet WJ, Schwarting A, Meyer zum Buschenfelde KH. Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin Exp Immunol 1994; 97: 458-465
55. Savage CO, Gaskin G, Pusey CD, Pearson JD. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol 1993; 1: 190-195
56. Ballieux BE, Zondervan KT, Kievit P et al. Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC? Clin Exp Immunol 1994; 97: 52-60
57. Berger SP, Seelen MA, Hiemstra PS et al. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J Am Soc Nephrol 1996; 7: 694-701
58. Yang JJ, Kettritz R, Falk RJ, Jennette JC, Gaibo ML. Apoptosis of endothelial cells induced by neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 1996; 149: 1617-1626
59. Ballieux BE, Hiemstra PS, Klar Mohamad N et al. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol 1994; 24: 3211-3215
60. Mayet WJ, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993; 94: 440-446
61. Mayet WJ, Schwarting A, Orth T, Duchmann R, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol 1996; 103: 259-267
62. Johnson PA, Alexander HD, McMillan SA, Maxwell AP. Up-regulation of the endothelial cell adhesion molecule intercellular adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis. Clin Exp Immunol 1997; 108: 234-242
63. Sibelius U, Hattar K, Schenkel A et al. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inducters of human endothelial cell signaling and leakage response. J Exp Med 1998; 187: 497-503
64. De Bandt M, Ollivier V, Meyer O et al. Induction of interleukin 1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum 1997; 40: 2030-2038
65. Mayet WJ, Csernok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde KH. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 1993; 82: 1221-1229
66. King WJ, Adu D, Daha MR et al. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 1995; 102: 98-105
67. Pendergraft WF, Yang JJ, Tuttle R et al. Myeloperoxydase (MPO) and proteinase 3 (Pr3) are not expressed by endothelial cells. Clin Exp Immunol 1998; 112 [Suppl]: 19 (Abstract)
68. Cohen Tervaert JW. The value of serial ANCA testing during follow-up studies in patients with ANCA associated vasculitides. A review. J Nephrol 1996; 9: 232-240
69. Kallenberg CGM, Mulder AH, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93: 675-682
70. Jayne DR, Weetman AP, Lockwood CM. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991; 84: 476-481
71. Cohen Tervaert JW, Mulder AHL, Kallenberg CGM, Stegeman CA. Measurement of IgG3 levels of anti-proteinase 3 antibodies is useful in monitoring disease activity in Wegener's granulomatosis. J Am Soc Nephrol 1994; 5: 828 (Abstract)
72. van de Wiel BA, Dolman KM, van der Meer Gerritsen CH, Hack CE, von dem Borne AE, Goldschmeding R. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 1992; 90: 409-414
73. Daouk GH, Palsson R, Arnaout MA. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 1995; 47: 1528-1536
74. Dolman KM, Stegeman CA, van de Wiel BA et al. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol 1993; 93: 405-410
75. Henshaw TJ, Malone CC, Gabay JE, Williams RC, Jr. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1994; 37: 104-112
76. Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL, Elkon KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 1992; 149: 1409-1415
77. Williams RC, Jr., Staud R, Malone CC, Payabyab J, Byres L, Underwood D. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J Immunol 1994; 152: 4722-4737
78. Chang L, Binos S, Savige J. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Clin Exp Immunol 1995; 102: 112-119
79. Griffith ME, Coulthart A, Pemberton S, Pusey CD. c-ANCA recognise a restricted number of linear epitopes of proteinase 3 which involve the catalytic site. Sarcoidosis Vasc Diff Lung Dis 1996; 13: 256 (Abstract)
80. Audrain MA, Baranger TA, Moguilevski N et al. Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies. Clin Exp Immunol 1997; 107: 127-134
81. Short AK, Lockwood CM. Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis. Clin Exp Immunol 1997; 110: 270-276
82. Chapman PT, Short AK, Lockwood CM. The use of Biosensor technology in epitope mapping studies on human myeloperoxidase. The Immunologist 1997; (Abstract)
83. Tomizawa K, Mine E, Fujii A et al. A panel set for epitope analysis of myeloperoxidase ( MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol 1998; 18: 142-152
84. Segelmark M, Persson B, Hellmark T, Wieslander J. Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? Clin Exp Immunol 1997; 108: 167-174
85. Griffin SV, Lockwood CM. Different potential of anti-myeloperoxidase (MPO) antibodies from patients with polyangiitis compared to Wegener's granulomatosis to interfere with the inhibition of MPO by caeroloplasmin. Clin Exp Immunol 1998; 112: 54 (Abstract)
86. Franssen CF, Gans RO, Arends B et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47: 193-199
87. Cohen Tervaert JW, Elema JD, Kallenberg CGM. Clinical and histopathological association of 29kD-ANCA and MPO-ANCA. APMIS Suppl. 1990; 19:35
88. Franssen CF, Huitema MG, Muller Kobold AC et al. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxydase from patients with crescentic glomerulonephritis. Kidney Int 1998; in press
89. Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980; 281: 836-838
90. Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990; 113: 656-663
91. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335: 16-20
92. Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Leukocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 1998; 37: 901-907
93. Halbwachs Mecarelli L, Bessou G, Lesavre P, Lopez S, Witko Sarsat V. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 1995; 374: 29-33
94. Brouwer E, Huitema MG, Mulder AH et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994; 45: 1120-1131
95. Haller H, Eichhorn J, Pieper K, Goebel U, Luft FC. Circulating leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephrol 1996; 7: 40-48
96. Muller Kobold AC, Mesander G, Stegeman CA, Kallenberg CGM, Cohen Tervaert JW. Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody associated vasculilis? Clin Exp Immunol 1998; 114: 491-499
97. Rastaldi MP, Ferrario F, Tunesi S, Yang L, D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1a expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis 1996; 27: 48-57
98. Pike PC. The vole of the monocyte and macrophage in the pathogenisis of vasculitis. In: LeRoy EC, ed. Systemic Vasculitis. The Biological Basis. Marcel Dekker, New York; 1992: 129-147
99. Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 1998; in press
100. Bruyn JA, Dinklo NJCM. Distinct patterns of expression of intracellular adhesion molecule-1, vascular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 1993; 69: 329-335
101. Brouwer E, Huitema MG, Heeringa P, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Upregulation of adhesion molecules in renal biopsies from patients with Wegener's granulomatosis. Clin Exp Immunol 1993; 93 [Suppl 1]: 22 (Abstract)
102. Cohen Tervaert JW, Kallenberg CGM. Cell adhesion molecules in vasculitis. Curr Opin Rheumatol 1997; 9: 16-25
103. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667: 324-331
104. Stegeman CA, Cohen Tervaert JW, Huitema MG, de Jong PE, Kallenberg CGM. Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular adhesion molecule 1, and E-selectin in patients with Wegener's granulomalosis. Arthritis Rheum 1994; 37: 1228-1235
105. Wang CR, Liu MF, Tsai RT, Chuang CY, Chen CY. Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anti-cardiolipin, and anti-neutrophil cytoplasma antibodies in patients with vasculitis. Clin Rheumatol 1993; 12: 375-380